Healthy Clinical Trial
Official title:
Analysis of Kinematical and Muscular Fatigue in Long Distance Swimmers
Verified date | October 2023 |
Source | Universita degli Studi di Genova |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
During a submaximal task, gradual muscle fatigue occurs, which inevitably results in a decline in performance (mechanical failure). Elite athletes are known to employ unconscious compensatory strategies during fatiguing submaximal tasks in an attempt to delay the onset of mechanical failure as long as possible. The purpose of this study was to gain valuable insight into the strategies used by elite swimmers to cope with mechanical failure. Twenty-two swimmers were subjected to a swim test consisting of swimming as long as possible at a predetermined and controlled pace. A light strip positioned at the bottom of the pool allows athletes to get feedback on which gait to keep. The kinematics (stroke rate, stroke length, and efficiency index) and electrical activity of 10 muscle groups were analyzed and compared at the beginning of the test (non-fatiguing conditions), just before the athlete lost the ability to maintain the predetermined pace (pre-mechanical failure), and after the athlete lost the ability to maintain the pace (mechanical failure). It is hypothesized that as fatigue becomes more pronounced and the point of inability to maintain a predetermined speed is approached, increased EMG activity will occur in key muscles while other muscle groups may show more obvious signs of fatigue. In addition, changes in the rhythm and coordination of upper limb movements may occur.
Status | Completed |
Enrollment | 23 |
Est. completion date | August 1, 2023 |
Est. primary completion date | March 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 16 Years to 24 Years |
Eligibility | Inclusion Criteria: 1. Middle- or long-distance swimmer specializing in front crawl 2. At least 3 years of experience in international competition 3. Daily use of flashing light for pace control in aerobic, anaerobic threshold and maximum oxygen consumption training. Exclusion Criteria: 1) Presence of muscle pain or soreness that could prevent the athlete from performing at their best |
Country | Name | City | State |
---|---|---|---|
Italy | Università degli Studi di Genova | Genova |
Lead Sponsor | Collaborator |
---|---|
Universita degli Studi di Genova |
Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Flexor Carpi Radialis muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Biceps Brachii muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Triceps Brachii caput lateralis muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Deltoideus Lateralis muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Latissimus Dorsi muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Superior Trapezius muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Erector Spinae muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Pectoralis Major pars clavicularis muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Rectus Femoris muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Biceps Femoris muscle activity | Electromyographic signal analysis (Root Mean Square) | up to 10 minutes | |
Primary | Kinematic parameters | stroke frequency (time required to complete a stroke cycle) | up to 10 minutes | |
Primary | Kinematic parameters | stroke length (distance traveled during each stroke cycle)) | up to 10 minutes | |
Secondary | Flexor Carpi Radialis muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Biceps Brachii muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Triceps Brachii caput lateralis muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Deltoideus Lateralis muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Latissimus Dorsi muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Superior Trapezius muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Erector Spinae muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Pectoralis Major pars clavicularis muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Rectus Femoris muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes | |
Secondary | Biceps Femoris muscle fatigue | time-course evolution of the median frequency of the power density spectrum (MF [Hz]) of the sEMG signal | up to 10 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |